Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study

Liraglutide (LIRA) treatment is associated with the dose-dependent reduction of weight. Higher doses are more effective than lower doses, although higher doses are also more poorly tolerated. Metformin may enhance the weight-lowering potential of LIRA via the stimulatory modulation of incretin in ad...

Descripción completa

Detalles Bibliográficos
Autores principales: JENSTERLE, MOJCA, GORICAR, KATJA, JANEZ, ANDREJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812364/
https://www.ncbi.nlm.nih.gov/pubmed/27073422
http://dx.doi.org/10.3892/etm.2016.3081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812364/
https://www.ncbi.nlm.nih.gov/pubmed/27073422
http://dx.doi.org/10.3892/etm.2016.3081

Ejemplares similares